| 書目名稱 | Pharmacoresistance in Epilepsy | | 副標(biāo)題 | From Genes and Molec | | 編輯 | Luisa Rocha,Esper A. Cavalheiro | | 視頻video | http://file.papertrans.cn/746/745658/745658.mp4 | | 概述 | Contains the most up-to-date information on the development of pharmacoresistance in epileptic disorders.Discusses novel therapeutic strategies to counteract the development of pharmacoresistance.Of i | | 圖書封面 |  | | 描述 | .Although more than 10 new antiepileptic drugs have been developed in the past decade, epilepsy remains resistant to drug therapy in about one third of patients, many of whom struggle with the disease their entire lives. Managing these patients is a challenge and requires a structured multidisciplinary approach. The book includes chapters on all issues related to pharmacoresistance in epilepsy and describes recent developments in the pathogenesis and treatment of this disorder. It addresses abnormalities in inhibitory mechanisms, epilepsy-related changes to the immune system, development of pharmacoresistance caused by chronic exposure to antiepileptic drugs, and novel therapeutic strategies for preventing or slowing down the progression of the disease. .Clinicians and basic scientists alike will find up-to-date information on the development of pharmacoesistance, as well as reviews of mechanisms associated with epilepsy that may help them consider novel strategies for preventingthe development of pharmacoresistance in the first place. The book also features information on new therapeutic strategies for control of epilepsy, such as transcutaneous electrical stimulation and virtual | | 出版日期 | Book 20131st edition | | 關(guān)鍵詞 | epilepsy; neurotoxicity; pharmacoresistance; therapeutic strategies in epilepsy | | 版次 | 1 | | doi | https://doi.org/10.1007/978-1-4614-6464-8 | | isbn_ebook | 978-1-4614-6464-8 | | copyright | Springer Science+Business Media, LLC 2013 |
The information of publication is updating
|
|
|Archiver|手機(jī)版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2026-1-31 08:17
發(fā)表于 2025-3-21 18:22:03
